D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months
Status: | Completed |
---|---|
Conditions: | Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 18 - 75 |
Updated: | 12/14/2016 |
Start Date: | September 2008 |
End Date: | December 2016 |
A Cohort Study to Test That There is a Low Risk of Recurrent VTE in Patients With a First Episode of Unprovoked VTE Who Stop Anticoagulant Therapy After 3 Months of Treatment in Response to Negative D-dimer Testing
The purpose of this study is to determine if the risk of recurrent venous thromboembolism
(VTE) after stopping therapy is low and acceptable in patients with a first unprovoked
proximal deep vein thrombosis (DVT) or pulmonary embolism (PE) who have completed 3 months
of therapy and who have a negative D-dimer test on therapy and 1 month after stopping
therapy.
(VTE) after stopping therapy is low and acceptable in patients with a first unprovoked
proximal deep vein thrombosis (DVT) or pulmonary embolism (PE) who have completed 3 months
of therapy and who have a negative D-dimer test on therapy and 1 month after stopping
therapy.
Inclusion Criteria:
1. Be >= 18 years of age
2. Have had ONE episode of unprovoked proximal DVT and/or PE
3. Have completed 3 uninterrupted months of warfarin therapy (target INR of 2.0-3.0)
Exclusion Criteria:
1. Another indication for long-term anticoagulation (e.g., atrial fibrillation)
2. A high risk of bleeding as evidenced by any of the following:
- Age greater than 75 years
- Previous episode of major bleeding where the cause was not effectively treated
- Known chronic thrombocytopenia with a platelet count of less than 120,000 x 10^9
/L
- Known chronic renal impairment with a creatinine of more than 150 mumols /litre
(1.7 mg/dl)
- Known chronic liver disease with a total bilirubin of more than 25 mumols /litre
(1.5 mg/dl)
- Active peptic ulcer disease
- Poor compliance with, or control of, anticoagulant therapy during initial
treatment
- Requires dual antiplatelet therapy (e.g. aspirin and clopidogrel)
3. A vena caval filter
4. Has had D-dimer testing performed within 2 months of potential enrollment other than
for evaluation of suspected recurrent VTE that was not confirmed
5. Has a life expectancy less than 5 years
6. Is unable to attend follow-up visits because of geographic inaccessibility
7. Is participating in a competing clinical investigation
We found this trial at
8
sites
Click here to add this to my saved trials
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Henry Ford Hospital Founded in 1915 by auto pioneer Henry Ford and now one of...
Click here to add this to my saved trials
University of Iowa Hospitals and Clinics University of Iowa Hospitals and Clinics—recognized as one of...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials